PD-L1 has a heterogeneous and dynamic expression in gastric cancer with implications for immunoPET
Dina Ibrahim(Mallinckrodt (United States)), Patrícia M. R. Pereira(Memorial Sloan Kettering Cancer Center)
Cited by 11
Related Papers
Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer
|Nature Communications|2022|40
Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors
|Journal of Nuclear Medicine|2019|32
Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition
|Journal of Nuclear Medicine|2020|5
PDX Models in Theranostic Applications: Generation and Screening for B Cell Lymphoma of Human Origin
|Molecular Imaging and Biology|2024|5
Caveolin-1 temporal modulation enhances trastuzumab and trastuzumab-drug conjugate efficacy in heterogeneous gastric cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2021|0